# New Treatment Response in People With and Without Cirrhosis From Chronic Hepatitis C

> **NCT01888900** · PHASE2 · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 35 (actual)

## Conditions studied

- Cirrhosis
- Chronic Hepatitis C
- Hepatitis C
- Hepatitis C, Chronic

## Interventions

- **DRUG:** DUAL
- **DRUG:** QUAD

## Key facts

- **NCT ID:** NCT01888900
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2017-02-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01888900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01888900, "New Treatment Response in People With and Without Cirrhosis From Chronic Hepatitis C". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT01888900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*